ISSN (Print): 1570-1808 ISSN (Online): 1875-628X Volume 18, 12 Issues, 2021
Download PDF Flyer
Open Access Funding Promote Your Article
ISSN (Print): 1570-1808 ISSN (Online): 1875-628X
Aims & Scope Abstracted/Indexed in
Science Citation Index ExpandedTM, Journal Citation Reports/Science Edition, InCites, Chemistry Citation Index®, Current Contents®/Physical, Chemical and Earth Sciences, ISI Alerting Service, Scopus, EMBASE, Chemical Abstracts Service/SciFinder, TOC Premier, ProQuest, ChemWeb, Google Scholar, Genamics JournalSeek, MediaFinder®-Standard Periodical Directory, PubsHub, Index Copernicus, J-Gate, CNKI Scholar, Suweco CZ, Ulrich's Periodicals Directory, JournalTOCs and Dimensions.
Ranking and Category:
Submit Abstracts / Manuscripts Online Animated Abstract Submission
View Full Editorial Board
Current: 1.169 5 - Year: 0.965
Journal Home Editorial Policies Publishing Ethics Self Archiving Policies Reviewer Guidelines Instructions for Authors Free Copies Online Open Access Articles Most Cited Articles Advertise With Us Most Accessed Articles Highlighted Article Trial Requests Library Recommendation Most Popular Articles Thematic Issues Special Issue Submission Subscribe
"Letters in Drug Design & Discovery should be available in every library in the pharmaceutical industry and in universities." R. F. Borne, Associate Director Laboratory for Applied Drug Design and Synthesis, The University of Mississippi, USA
I would like to thank Bentham Science Publishers for their peerless effort to keep up scientists and students updated with the latest science and research work. Actually, Bentham assists researchers to achieve their goals to spread their reputation worldwide. I have experienced sincere, efficient and effective communication while dealing with Bentham team members. I intend to submit my work to Bentham and try to pick up journals that match my research profile. I have submitted a recent work to Medicinal Chemistry and nowadays I am drafting a manuscript targeting Current Pharmaceutical Design. Honestly, no words neither sentences would express my gratefulness and admiration. Bentham has offered my institution three months trial to access their journal lists and surf on its Board. This free access trial fulfills my literature review and broadens my horizon to absorb the recent research in pharmaceutical sciences and medicinal chemistry. Finally, I wish Bentham more success and achievement!
Has contributed: CETP Inhibitory Activity of Chlorobenzyl Benzamides: QPLD Docking, Pharmacophore Mapping and Synthesis.
Synthesis of New Bis-pyrazolines Endowed with Potent Antifungal Activity against Candida albicans and Aspergillus niger
Volume: 18 Issue: 1 Pp: 3-15 Belgin Sever, Mehlika Dilek Altintop* and Ahmet Özdemir DOI: 10.2174/1570180817999201008155247
3,4,5-Trisubstituted-1,2,4-triazole Derivatives as Antiproliferative Agents: Synthesis, In vitro Evaluation and Molecular Modelling
Volume: 17 Issue: 12 Pp: 1502-1515 Leyla Yurttaş*, Asaf Evrim Evren, Aslıhan Kubilay, Halide Edip Temel and Gülşen Akalın Çiftçi DOI: 10.2174/1570180817999200712190831
Comparison in the Glucose Response of Flexible Liposomes Loaded with Insulin with the Addition of Different Surfactants in an Experimental Diabetes Model open access plus
Volume: 17 Issue: 6 Pp: 787-798 Sara Melisa Arciniegas , Sergio Andres Saavedra , Danaé Balderas , Sara del Carmen Caballero, María Josefa Bernad, Julio Cesar Sánchez , María Isabel Gracia, Héctor Ariel Rico and Dinorah Vargas * DOI: 10.2174/1570180816666191024102231
Lapatinib as a Dual Tyrosine Kinase Inhibitor Unexpectedly Activates Akt in MDA-MB-231 Triple-Negative Breast Cancer Cells promotion: free to download
Volume: 17 Issue: 8 Pp: 1060-1063 Parham Jabbarzadeh Kaboli * and King-Hwa Ling DOI: 10.2174/1570180817666200212125658
Structure-based Drug Design Strategies in the Development of Small Molecule Inhibitors Targeting Bcl-2 Family Proteins open access plus
Volume: 17 Issue: 8 Pp: 943-953 Zhe Yin, Donglin Yang, Jun Wang and Yuequan Jiang* DOI: 10.2174/1570180817666200213114759
Development of Phthalimide-Donepezil Hybrids as Potent Multitarget- Directed Ligands for the Treatment of Alzheimer’s Disease
Volume: 17 Issue: 9 Pp: 1155-1163 Lintao Yu, Jian Shi, Xinfeng Cheng, Keren Wang, Shuang Liu, Wenmin Liu and Zhipei Sang* DOI: 10.2174/1570180817999200420120519
Molecular Docking and QSAR Studies of Coumarin Derivatives as NMT Inhibitors: Simple Structural Features as Potential Modulators of Antifungal Activity
Volume: 17 Issue: 10 Pp: 1293-1308 Sapna Jain Dabade, Dheeraj Mandloi* and Amritlal Bajaj DOI: 10.2174/1570180817999200617105711
Design, Synthesis, In vitro and In silico Evaluation of New Hydrazonebased Antitumor Agents as Potent Akt Inhibitors
Volume: 17 Issue: 11 Pp: 1380-1392 Emine Merve Güngör, Mehlika Dilek Altıntop*, Belgin Sever and Gülşen Akalın Çiftçi DOI: 10.2174/1570180817999200618163507
Synthesis, Characterization, and Molecular Docking Studies of N-Acylated Butyro and Valerolactam Derivatives with Antiproliferative and Cytotoxic Activities open access plus
Volume: 17 Issue: 6 Pp: 725-730 Mark Tristan J. Quimque, Mark John P. Mandigma, Justin Allen K. Lim, Simon Budde, Hans-Martin Dahse, Oliver B. Villaflores, Arnold V. Hallare and Allan Patrick G. Macabeo* DOI: 10.2174/1570180816666190716141524
Design, Synthesis and Biological Evaluation of 3-(2-(benzo[d]thiazol-2- ylthio)acetamido)benzoic Acid Derivatives as Inhibitors of Protein Tyrosine Phosphatase 1B
Volume: 18 Issue: 1 Pp: 46-56 Monika Rakse*, Chandrabose Karthikeyan, Narayana Subbiah Hari Narayana Moorthy and Ram Kishore Agrawal DOI: 10.2174/1570180817999200819122350
Novel Benzimidazole Derivatives: Cytotoxic and Apoptotic Properties on Lung Cancer Cell Line
Volume: 17 Issue: 10 Pp: 1227-1236 Leyla Yurttaş*, Gülşen Akalin Çiftçi, Mehmet Onur Aksoy and Şeref Demirayak DOI: 10.2174/1570180817999200513091613
Molecular Docking Analysis of Flavonoid Compounds with Matrix Metalloproteinase- 8 for the Identification of Potential Effective Inhibitors
Volume: 18 Issue: 1 Pp: 16-45 Amir Taherkhani, Athena Orangi, Shirin Moradkhani and Zahra Khamverdi* DOI: 10.2174/1570180817999200831094703
The Potency of Catechin from Gambir (Uncaria gambir Roxb.) as a Natural Inhibitor of MurA (1UAE) Enzyme: In vitro and In silico studies
Volume: 17 Issue: 12 Pp: 1531-1537 Bella Riyana, Desi Harneti Putri Huspa, Mieke Hemiawati Satari and Dikdik Kurnia* DOI: 10.2174/1570180817999200714104737
High Anti-cancer Activity, Low Animal Toxicity, and Structure Activity Relationships of Curcumin Analogs
Volume: 17 Issue: 11 Pp: 1439-1455 Sen-Chuan Song, Yu-Liang Mai, Hua-Hong Shi, Bing Liao* and Fei Wang* DOI: 10.2174/2352096513999200714103641
Evaluating Phenyl Propanoids Isolated from Citrus medica as Potential Inhibitors for Mitotic kinesin Eg5
Volume: 17 Issue: 11 Pp: 1355-1363 Himesh Makala, Venkatasubramanian Ulaganathan*, Aravind Sivasubramanian, Narendran Rajendran and Shankar Subramanian DOI: 10.2174/1570180817999200630125449
Design, Synthesis and Biological Evaluation: 5-amino-1H-pyrazole-1- carbonyl derivatives as FGFR Inhibitors
Volume: 17 Issue: 11 Pp: 1330-1341 Yan Zhang and Niefang Yu* DOI: 10.2174/1570180817999200608140628
Synthesis and Evaluation of Dapagliflozin Ester Prodrugs with Improved Hygroscopicity and Thermal Stability
Volume: 17 Issue: 11 Pp: 1409-1421 Si Young Sung, Yu Na Chae, Dae Young Lee, Kyeong Min Kim, Eun Jung Kim, Ji Hye Han, Wook Kim and Sung-Hwa Yoon* DOI: 10.2174/1570180817999200618162949
Drug Re-purposing from SARS-CoV Led the Identification of Potential Candidate Drug Target and Alternate Drug Molecules Against SARSCoV- 2 promotion: free to download
Volume: 17 Issue: 10 Pp: 1325-1327 PV Parvati Sai Arun*, Razak Hussain, Yusuf Akhter, Mandava Venkata Basaveswara Rao, Perugu Shyam and Sailu Yellaboina DOI: 10.2174/1570180817999200730190600
view more
